Trial Details
UNKNOWNBasic Information
| Clinical ID | c1698 |
|---|---|
| Identifier | NCT04655729 |
| Trial Title | Biomarkers to Predict and Monitor Response to Infliximab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | Massachusetts General Hospital |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2019-11-18 |
|---|---|
| Primary Completion Date | 2022-11-30 |
| Completion Date | 2023-01-01 |